A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease

Key facts

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Intervention

TQ05105 Tablet(drug)

Enrollment

45 enrolled

Eligibility

18 years · All sexes

Timeline

2021 – 2026

Study locations (12)

• The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, Anhui, China
• Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
• Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
• Guangzhou First People's Hospital, Guangzhou, Guangdong, China
• The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
• The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
• The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
• Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
• Tongji Hospital Tongji Medical College of HUST, Wuhan, Hubei, China
• The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
• Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, Tianjin Municipality, China
• The First Affiliated Hospital, Zhejiang University School of Medicine, Hanzhou, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07394608
  Paired Non-invasive VNS in Adolescent Cerebral Palsy Rehabilitation
  Icahn School of Medicine at Mount Sinai
• RECRUITINGPHASE2NCT07124078
  A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
  Incyte Corporation
• RECRUITINGEARLY PHASE1NCT07355868
  Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
  Regend Therapeutics
• RECRUITINGNANCT06857929
  "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"
  IMDEA Food
• RECRUITINGPHASE1NCT07389044
  A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
  IntegerBio
• RECRUITINGNCT07127926
  Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
  M.D. Anderson Cancer Center
• RECRUITINGPHASE1NCT07138196
  A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease
  Qurient Co., Ltd.
• ACTIVE NOT RECRUITINGNCT07321080
  Central Sensitisation in Nociceptive and Neuropathic Pain
  IRCCS Centro Neurolesi Bonino Pulejo

See all trials for Chronic graft versus host disease →